New Patent Registration

February 4, 2025

đź’ˇ What? 

Vita Motus has registered a new patent describing a new approach to smoothly correct atherosclerosis epigenesis using Angelica extract.

🏆 How?

Angelica extract modifies the microRNA profile in human plasma by lowering the expression levels of microRNAs that promote atherosclerosis while increasing the levels of molecules that inhibit atherosclerosis.

🚀 Why is this important? 

Thus, it is possible to incorporate plant extract intake into daily life and gain all the natural health benefits without side effects.

New ISO Certification

🏆 We’re proud to share that Vita Motus AG has once again been awarded the ISO

Exosomes Digest (4/4 August 2025)

We have collected the most exciting new research in the field of genetics and cellular reserach.

Thank you ISEV 2025!

We attended ISEV 2025, one of the world’s leading conferences focused on extracellular vesicles. It was